Treadway J L, Frattali A L, Pessin J E
Department of Physiology and Biophysics, University of Iowa, College of Medicine, Iowa City 52242.
Biochemistry. 1992 Dec 1;31(47):11801-5. doi: 10.1021/bi00162a018.
We have previously demonstrated that isolated insulin and IGF-1 alpha beta half-receptors can be reconstituted into a functional alpha 2 beta 2 hybrid receptor complex [Treadway et al. (1989) J. Biol. Chem. 264, 21450-21453]. In the present study, we have examined this assembly process by determining the effect of ligand occupancy and Mn/MgATP binding on the dimerization of mutant and wild-type insulin and IGF-1 alpha beta half-receptors. IGF-1 or Mn/MgAMPPCP binding to wild-type IGF-1 alpha beta half-receptors resulted in the specific assembly of the alpha beta half-receptors into an alpha 2 beta 2 heterotetrameric IGF-1 holoreceptor complex. Similarly, insulin binding to the kinase-deficient mutant (A/K1018) insulin alpha beta half-receptor also resulted in the specific assembly into an alpha 2 beta 2 holoreceptor complex. In contrast, Mn/MgAMPPCP treatment of A/K1018 mutant insulin alpha beta half-receptors did not induce heterotetramer assembly, consistent with the inability of this mutant receptor to bind ATP. The ability of the insulin alpha beta receptors to assemble with the IGF-1 alpha beta half-receptors was used to examine the intermolecular subunit interactions responsible for dimerization. In the presence of Mn/MgAMPPCP, the wild-type insulin and wild-type IGF-1 alpha beta half-receptors were observed to assemble into an insulin/IGF-1 alpha 2 beta 2 hybrid receptor complex. Similarly, a combination of insulin and IGF-1 induced hybrid receptor formation between wild-type IGF-1 and A/K1018 mutant insulin alpha beta half-receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
我们之前已经证明,分离出的胰岛素和IGF-1αβ半受体可以重新组装成功能性的α2β2杂合受体复合物[Treadway等人(1989年),《生物化学杂志》264卷,21450 - 21453页]。在本研究中,我们通过确定配体占据以及Mn/MgATP结合对突变型和野生型胰岛素及IGF-1αβ半受体二聚化的影响,来研究这一组装过程。IGF-1或Mn/MgAMPPCP与野生型IGF-1αβ半受体结合,导致αβ半受体特异性组装成α2β2异源四聚体IGF-1全受体复合物。同样,胰岛素与激酶缺陷型突变体(A/K1018)胰岛素αβ半受体结合,也导致特异性组装成α2β2全受体复合物。相比之下,用Mn/MgAMPPCP处理A/K1018突变体胰岛素αβ半受体并未诱导异源四聚体组装,这与该突变受体无法结合ATP一致。胰岛素αβ受体与IGF-1αβ半受体组装的能力被用于研究负责二聚化的分子间亚基相互作用。在存在Mn/MgAMPPCP的情况下,观察到野生型胰岛素和野生型IGF-1αβ半受体组装成胰岛素/IGF-1α2β2杂合受体复合物。同样,胰岛素和IGF-1的组合诱导了野生型IGF-1与A/K1018突变体胰岛素αβ半受体之间形成杂合受体。(摘要截选至250词)